Activity Description: Interactive Module Series
This is a series of 8 interactive modules. Each module builds on the content presented in the previous one, so it is highly recommended that you proceed through the curriculum in sequence. As biosimilar guidance evolves in the United States and these biologics are studied and FDA-approved for use, it will be important for clinicians to understand how biosimilars’ characteristics overlap with, and differ from, other available biologic therapies, so that effective treatment selection and monitoring, and related patient education, can be achieved.

Begin Activity

 

Updates

  • The France Foundation, ASCP, and ASH Awarded 2017 Outstanding Live Continuing Education Activity by the Alliance for Continuing Education in the Health Professions

    Read More ...

  • The France Foundation Receives ACCME Accreditation with Commendation as a Provider of Continuing Medical Education

    Read More ...

Featured Online Activities